I read the release and some other copy on the website. Not that I understood much of it, except it seems like fibroblasts are better than stem cells in the treatment of a number of diseases. Tying it in to LBSR, I would think that going public with this company would make PO even better off financially if the company's products are as promising as the website makes them sound. Forward looking statements but an impressive long list of references. FBLG, closed at $17.48 with 289,974 shares traded. It was down $11.62 but the high was $46. Not that I have any idea what that means.